{"id":"NCT03923959","sponsor":"Lancaster General Hospital","briefTitle":"Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population","officialTitle":"Evaluation of Tranexamic Acid Prior to Surgery in the Geriatric Hip Fracture Population for the Reduction of Post-Operative Blood Transfusion","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-02-01","primaryCompletion":"2022-12-09","completion":"2022-12-09","firstPosted":"2019-04-23","resultsPosted":"2024-10-10","lastUpdate":"2024-10-10"},"enrollment":283,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hip Fractures"],"interventions":[{"type":"DRUG","name":"Tranexamic Acid Injectable Solution","otherNames":["Cyklokapron"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Intervention","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The overall design of the study is a prospective, double-blinded, randomized study in the geriatric hip fracture population comparing those who receive intravenous tranexamic acid prior to incision to those who receive a placebo.","primaryOutcome":{"measure":"Count of Participants With Acute Post-operative Transfusion of Packed Red Blood Cells.","timeFrame":"3 Months","effectByArm":[{"arm":"Intervention","deltaMin":118,"sd":null},{"arm":"Placebo","deltaMin":111,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.966"}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["27492116","20190103","25378512","19007970","8874456","30007789","29699826","25889413","24196467","24196466","10919295","19483232","26703193","28244907","22704229","27113948","25471907","24997651","18929686"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":146},"commonTop":["Mild","Moderate"]}}